from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0345/-

LFCtreatmentdescriptionclass of inhibitor

-0.678

Amikacinug/mL Amikacintranslation

-0.644

Cap5-10ug/mL Capreomycintranslation

-0.266

Rox10-50 ug/mL Roxithromycintranslation

-0.205

SM2-5 ug/mL Streptomycintranslation

0.135

Tet5-10 ug/mL Tetracyclinetranslation

-0.018

Rif0.2-5ug/mL Rifampicintranscription

-0.475

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.043

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.737

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.195

CPZ10-50 ug/mL Chlorpromazinerespiration

0.131

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.430

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.727

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.738

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.389

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.544

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.414

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.016

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.155

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.428

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.141

KCN5-20 ug/mL Potassium cyaniderespiration

-0.017

NaN30.2-2 mM Sodium aziderespiration

-0.962

Nigericin50 uM Nigericinrespiration

-0.259

TRC10-150 ug/mL Triclosanrespiration

0.245

TRZ10-25 ug/mL Thioridazinerespiration

-0.062

Valinomycin0.5-10 uM Valinomycinrespiration

-1.531

ZnSO42 mM ZnSO4respiration

-0.572

menadione6-10 ug/mL Menadionerespiration

0.684

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.999

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.430

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.943

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.252

NRP_1Non-replicating persistence stage 1dosRassociated

-0.539

Amp0.2mg/mL AmpicillincellWall

-0.292

Cephalexin20-100 ug/mL CephalexincellWall

-0.207

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.253

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.654

EMB10-20 ug/mL EthambutolcellWall

0.465

Eta12-40 ug/mL EthionamidecellWall

1.291

INH0.2-0.4 ug/mL IsoniazidcellWall

0.200

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.020

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.858

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.588

BZA0.12 mg/mL BenzamidearomaticAmides

0.208

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.554

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.649

H2O24 mM hydrogen peroxideDNAdamaging

-0.594

Levo10 ug/mL LevofloxacinDNAdamaging

-0.645

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.661

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.249

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.682

UVUV-irradiationDNAdamaging

1.115

ARP41-4 ug/mL Antitubercular compound ARP4?

0.497

Antimycin12.5-50 ug/mL Antimycin A?

-0.348

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.790

PA_110-50 ug/mL Antitubercular compound PA-1?

0.917

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.390

PA8240.2-2 ug/mL PA-824?

0.553

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.381

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.094

Verapamil50 uM Verapamil?

-0.717

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.866

methoxatin10-20 ug/mL Methoxatin?